Become part of CSL Behring Medical Expert Portal

Featured content

Unlocking the next step in gene therapy for haemophilia: The end of the beginning?

Haematology

Symposia replays

Unlocking the next step in gene therapy for haemophilia: The end of the beginning?

The EAHAD 2024 symposium moderated by Jan Astermark explored patient and physician perspectives on gene therapy implementation one-year post-European approval of the first gene therapy fo...

From prophylactic treatment to gene therapy from a patient's perspective: Gabriel's journey

Haematology

Patient support

From prophylactic treatment to gene therapy: Gabriel's journey

Learn in this 6-minute video about Gabriel, who decided to choose gene therapy in early adulthood.

Haematology

Science updates

25 Jul 2022

AAV-based gene therapy

Explore the multi-step process of using recombinant AVV vectors for in vivo liver-directed gene transfer.

Expert views

Haematology

Expert views

Recombinant factor VIII in haemophilia A: Real-world evidence

Martin Olivieri highlights recent real-world studies of factor VIII replacement products and how those outcomes compare with clinical trial results.

Haematology

Expert views

Navigating pharmacoeconomics in haemophilia A

Eugenio Di Brino explores some of the most recent studies and discusses how these contribute to the bigger picture of decision-making in haemophilia A treatment.

Haematology

Expert views

Navigating pharmacoeconomics: a 101 guide to pharmacoeconomic analyses

Eugenio Di Brino discusses the basics of pharmacoeconomic analyses and how particular study designs can assess different outcomes.

Webinars on-demand

Haematology

Webinars on-demand

Gene therapy 2: HEMGENIX^® clinical practice

The webinar moderated by Frank Leebeek focused on the practical issues associated with HEMGENIX®, including the eligibility assessment process and the multidisciplinary team perspective on infusion da...

Haematology

Webinars on-demand

Gene therapy 1: HEMGENIX^® clinical studies

Moderated by Frank Leebeek, the webinar summarised the clinical development of HEMGENIX^® and provides an overview of the efficacy, safety and quality of life results from the Phase III (HOPE-B) study.

Haematology

Webinars on-demand

Female factors to consider in von Willebrand disease: Heavy menstrual bleeding and peri-partum care

This webinar moderated by Dr Paula James aimed to enhance disease awareness of von Willebrand disease (VWD) beyond the specialty of haematology.

Congress symposia

Haematology

Symposia replays

Unlocking the next step in gene therapy for haemophilia: The end of the beginning?

The EAHAD 2024 symposium moderated by Jan Astermark explored patient and physician perspectives on gene therapy implementation one-year post-European approval of the first gene therapy for haemophilia...

Haematology

Symposia replays

Gene therapy in haemophilia: the evolving patient-centric multidisciplinary journey

In this EAHAD 2023 symposium, a multidisciplinary panel of experts moderated by Michiel Coppens outlined the patient journey through life with haemophilia.

Haematology

Symposia replays

Advancing care for haemophilia: How do we keep up with the times?

Chaired by Niamh O'Connell, the ISTH 2022 symposium outlined the current care models and therapeutic options in haemophilia highlighting the need for a shift in care as new emerging therapies are bein...

Science updates

Haematology

Science updates

01 Apr 2024

EAHAD gene therapy database: a comprehensive resource of all gene therapy trials in haemophilia

Learn more about the current gene therapy trials in haemophilia A and B with the publically accessible EAHAD Gene Therapy database.

Haematology

Science updates

25 Mar 2024

EAHAD 2024 catch-up: access the latest findings on gene therapy in haemophilia

Explore patient and physician perspectives on gene therapy in haemophilia and get up to speed with new long-term data releases from gene therapy clinical trials in the EAHAD 2024 symposium replay.

Haematology